STAT3 and ulcerative colitis: 2’-Fucosyllactose inhibits STAT3-related signaling pathways in colonic tissue by suppressing STAT3 phosphorylation and palmitoylation, ultimately repairing the intestinal mucosal barrier in ulcerative colitis and reducing inflammatory responses (143).